首页> 外国专利> METHOD OF DIAGNOSIS OF PROSTATE CANCER (VERSIONS), METHOD OF EVALUATION OR MONITORING OF REACTION TO TREATMENT IN SUBJECTS WITH PROSTATE CANCER (VERSIONS), METHOD OF EVALUATION OF NECESSITY OF BIOPSY OF PROSTATE AND KIT

METHOD OF DIAGNOSIS OF PROSTATE CANCER (VERSIONS), METHOD OF EVALUATION OR MONITORING OF REACTION TO TREATMENT IN SUBJECTS WITH PROSTATE CANCER (VERSIONS), METHOD OF EVALUATION OF NECESSITY OF BIOPSY OF PROSTATE AND KIT

机译:诊断前列腺癌的方法(版本),对患有前列腺癌的受试者进行治疗的评估或监测的方法(版本),评估前列腺和小肠活检的必要性的方法

摘要

The invention relates to methods and kits for the diagnosis of prostate cancer (PCa) in a subject, for assessing or monitoring the response to a therapy in a subject having PCa or for monitoring the progression of prostate cancer PCa based on the detection of alteration in the expression levels of at least one gene selected from the group of PC A3, PSMA and PSGR. The invention relates as well to methods for assessing whether a subject has to be subjected to a prostate biopsy, said subject having a serum PSA range within 4-10 ng/mL.
机译:本发明涉及用于在受试者中诊断前列腺癌(PCa),评估或监测患有PCa的受试者中对疗法的反应或用于基于检测到的前列腺癌PCa的变化来监测前列腺癌PCa的进展的方法和试剂盒。选自PC A3,PSMA和PSGR的至少一种基因的表达水平。本发明还涉及用于评估受试者是否必须进行前列腺活检的方法,所述受试者的血清PSA范围为4-10ng / mL。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号